The growing importance of food safety, agricultural traceability and product verification creates business opportunities for Neogen Corporation (NEOG Quick QuoteNEOG - Free Report) and Where Food Comes From, Inc. (WFCF Quick QuoteWFCF - Free Report) . Although both companies serve the broader food industry, their business models differ. Neogen provides food and animal safety testing products and solutions, while Where Food Comes From specializes in independent verification, certification and traceability services across agricultural supply chains.

The Case for NEOG

Accelerating Core Revenue Growth: Neogen reported first-quarter fiscal 2027 revenues of $222.8 million, up 6.5% year over year, with core growth of 8.1%. Food Safety revenues increased 7.4% to $163.2 million, supported by an 11% increase in indicator testing and culture media products, including Petrifilm, and 7% growth in bacterial and general sanitation products.

Animal Safety revenues rose 4.2% to $59.6 million, benefiting from improved veterinary instrument supplies and the demand for insect control products. However, approximately 300 basis points of companywide core growth reflected favorable order timing and prior-year distributor inventory adjustments. This suggests that the underlying growth trajectory is more moderate than the headline figure.

Improving Operating Performance: NEOG's adjusted EBITDA increased to $41.6 million in the first quarter of fiscal 2027 from $35.5 million a year earlier, while its adjusted EBITDA margin expanded 170 basis points to 18.7%. Adjusted operating income rose to $36.5 million from $29.6 million, supported by higher revenues and operating leverage.

Free cash flow improved to $4.7 million from negative $13.1 million in the prior-year quarter, partly reflecting a $16-million reduction in capital expenditure. These improvements indicate progress in financial execution, although the company recorded a net loss of $11.9 million, highlighting the continuing gap between adjusted profitability and reported earnings.

Petrifilm Transition & Innovation Opportunities: Neogen completed validation of its first Petrifilm stock-keeping unit in August 2026 and expects to begin the planned multi-quarter manufacturing transition to its Lansing facility in November 2026. This represents an important step toward completing the integration of the former 3M Food Safety business and potentially improving manufacturing efficiency and supply reliability.

In October 2026, NEOG also announced a collaboration and equity investment in Hinalea Imaging Corp. to develop hyperspectral imaging solutions for food safety inspection. These initiatives could strengthen the product portfolio over time, although their financial contributions remain dependent on successful commercialization and execution.

Raised Guidance Supports Growth Prospects: Following its first-quarter performance, Neogen raised the fiscal 2027 revenue guidance to $885-$890 million from $880-$885 million and the adjusted EBITDA guidance to $181-$183 million from $180-$182 million. Management expects first-half core revenue growth of 3.5%, with the second quarter likely to record the weakest growth rate of the fiscal year.

The company is also increasing investments in research and development, commercial capabilities and enterprise systems. These initiatives support longer-term opportunities, although their near-term costs may limit margin expansion.

The Case for WFCF

Expanding Certification Portfolio: Where Food Comes From continues to diversify beyond its traditional beef verification business. The company provides auditing services covering more than 50 standards, including animal welfare, organic, non-GMO, gluten-free and sustainability certifications. Its RaiseWell Certified program, adopted by Whole Foods Market for beef supply certification in the first quarter of 2026, had enrolled more than 270,000 head of cattle by August 2026.

WFCF also intends to expand RaiseWell into chicken, turkey, pork, lamb and eggs. Additionally, its partnership with the Potato Sustainability Alliance creates opportunities in agricultural sustainability audits. These initiatives could support revenue diversification and strengthen customer relationships, although the timing and scale of future contributions remain uncertain.

Expanding Operating Margins: WFCF reported second-quarter 2026 revenues of $6.61 million, up approximately 1% year over year. Despite modest top-line growth, gross profit increased 9% to $2.68 million, with the gross margin expanding to 40.6% from 37.5%, reflecting cost efficiencies across all three revenue streams. Operating income increased 21% to $665,000 from $549,000.

For the first six months of 2026, operating income rose 39% year over year to $963,000, although the improvement also benefited from a roughly $400,000 compensation-related adjustment in the first quarter. These results indicate improved operating efficiency, but the sustainability of margin gains will depend on expense discipline and stronger revenue generation.

Conservative Balance Sheet & Shareholder Returns: WFCF ended June 2026 with cash and cash equivalents of $3.42 million compared with $3.20 million at 2025-end, and had minimal finance lease obligations. The operating cash flow totaled $1.46 million in the first half of 2026, compared with $1.81 million in the prior-year period.

The company repurchased 89,481 shares during the first six months, including 65,012 shares for approximately $809,000 in the second quarter. Since 2019, WFCF has returned $17.2 million to shareholders through buybacks and a special dividend. Its limited financial debt and history of capital returns provide flexibility, although lower operating cash generation warrants monitoring.

Renewed Acquisition Strategy:WFCF is exploring acquisition opportunities after approximately three years without a transaction. Management highlighted its historical approach of acquiring complementary certification capabilities, customers and revenue streams, with an emphasis on transactions that could become immediately or near-term accretive.

In August 2026, the company outlined plans to file a shelf registration statement to provide financing flexibility for potential acquisitions. This renewed focus could support expansion into additional verification markets and reduce the reliance on the cattle industry.

Challenges Facing NEOG & WFCF

NEOG's Debt & Integration Risks: Neogen had approximately $774 million in total debt and $172 million in cash as of Aug. 31, 2026, resulting in net debt of about $602 million. The company repaid $20 million of its term loan in June and another $10 million in September. Its proposed sale of the Genomics business to Zoetis is expected to generate $140 million in net proceeds, primarily for debt reduction, subject to regulatory reviews expected to conclude by December 2026.

Management anticipates net leverage falling below 3 times at closing and approaching 2.5 times by the end of the fiscal year. However, delays in the divestiture or the Petrifilm manufacturing transition could slow deleveraging and operational improvement. Continued spending on innovation and technology also creates near-term profitability considerations.

WFCF's Limited Revenue Growth & Beef Exposure: Where Food Comes From remains exposed to challenging conditions in the U.S. cattle industry, including historically low herd sizes and elevated beef prices. Management indicated in August 2026 that beef-related operations accounted for roughly 50% of revenues, making industry conditions significant to overall performance.

First-half 2026 revenues inched up 1.2% to $11.98 million, while verification and certification revenues rose 3.1% to $9.81 million. Professional services revenues declined to $513,000 from $655,000. Although new programs are helping diversify the business, their expansion has yet to generate substantial consolidated revenue growth. First-half net income declined to $505,000 from $593,000, partly reflecting a $299,000 adverse year-over-year swing in digital-asset valuations.

Which Stock Has the Edge?

NEOG has the edge in growth and operational improvement potential, supported by stronger demand across its two business segments, improving adjusted profitability, increased fiscal 2027 guidance and opportunities associated with the Petrifilm manufacturing transition. The expected Genomics divestiture could also improve financial flexibility by reducing leverage. Nevertheless, its investment case requires continued execution, particularly as the company works to convert adjusted operating gains into sustained profitability and free cash flow.

WFCF has the edge in balance-sheet conservatism and current profitability. Its diversified certification offerings, improving gross margin and disciplined approach to capital allocation support a comparatively less debt-dependent operating model. However, slow revenue growth, substantial beef-industry exposure and limited visibility into the financial contribution of newer programs constrain its near-term growth outlook.

Overall, NEOG appears better-positioned for investors prioritizing revenue growth and potential operating recovery, while WFCF offers a more conservative financial profile. NEOG's stronger growth comes with greater debt and execution risks, whereas WFCF's lower leverage is offset by its more modest business expansion.